Searched for
IPCA LABORATORIES SHARES
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a monthDespite a marginal rise in the Sensex, seven BSE 500 stocks touched fresh 52-week highs, signalling strong bullish momentum. Gland Pharma, ...
- Buy Ipca Laboratories, target price Rs 1,980: Motilal Oswal Financial ServicesMotilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly ...
- Ipca Laboratorties promoter sells 1.6% stake for Rs 600 croreUsha Madhukar Chandurkar, one of the promoters of Ipca Laboratories, on Wednesday divested a 1.6 per cent stake in the pharmaceutical compa...
- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- Stock Radar: This pharma stock is likely to top Rs 1000 levels in 1-2 months; time to buy?The stock rose from Rs 731 on 20 June to Rs 913 recorded on 20 September, which translates into an upside of 24% in 3 months. It hit a fres...
- Buy Ipca Laboratories, target price Rs 970: Nagaraj ShettiIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 23532.33 Crore) operating in Pharmaceutic...
- Hold Ipca Laboratories, target price Rs 790: Sharekhan by BNP ParibasIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 17596.92 Crore) operating in Pharmaceutic...
- Buy Ipca Laboratories, target price Rs 940: ICICI DirectIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20933.14 Crore) operating in Pharmaceutic...
- Buy Ipca Laboratories, target price Rs 1010: JM FinancialIpca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 20911.57 Crore) operating in Pharmaceutic...
- Hold Ipca Laboratories, target price Rs 865: Prabhudas LilladherAt CMP, the stock is trading at 23x FY25E factoring in near term recovery.
- Buy Ipca Laboratories, target Rs 915: NomuraBuy Ipca Laboratories Ltd. at a price target of Rs 915.
- Buy Ipca Laboratories, target Rs 837: Prabhudas LilladherBuy Ipca Laboratories Ltd. at a price target of Rs 837.0 .
- Ipca Labs Q2 profit zooms over 4-fold to Rs 55 croreStandalone total income from operations also rose to Rs 885.06 crore for the quarter under review as against Rs 753.72 crore for the same p...
- Ipca Labs Q2 net nosedives 81% to Rs 12 croreIpca Laboratories today reported a 80.92 per cent plunge in standalone net profit to Rs 11.69 crore for the quarter ended September 30.
- Buy Ipca Laboratories Ltd with a target of Rs 885: Sandeep Wagle"Ipca Laboratories Ltd is a 'BUY' call with a target of Rs 885 and a stop loss of Rs 838."
Load More
